Clinical trial
VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With…
NCT00171067 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171067 |
|---|---|
| Title | VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria |
| Official title | A Study to Evaluate the Effectiveness of Valsartan 320 mg in Combination With Lisinopril 20 mg Versus Monotherapy With Lisinopril 40 mg or Valsartan 320 mg in Hypertensive Patients With Microalbuminuria on the Reduction of Urinary Albumin Creatinine Ratio |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | valsartan, lisinopril |
| Enrollment | 134 |
| Start date | Jul 1, 2004 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | May 17, 2017 |
| Countries | Germany, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: